-->
The Service Tree lists all services in "branched" groups, starting with the very general and moving to the very specific. Click on the name of any group name to see the sub-groups available within it. Click on a service code to see its details and the providers who offer that service.
COVID-19 Treatment
Taxonomy Code: LT-1750.1620
Programs that are staffed by specialists who provide comprehensive treatment services for individuals with moderate to severe symptoms for COVID-19, who are at risk of progressing to severe illness and hospitalization. The spectrum of medical therapies to treat COVID-19 is growing and evolving rapidly, including both drugs approved by U.S. Food and Drug Administration (FDA) and drugs made available under FDA emergency use authorization (EUA). Current clinical management of COVID-19 consists of infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated. The FDA has approved one drug, remdesivir (Veklury), for the treatment of COVID-19 in certain situations, and a number of novel therapeutics (e.g., monoclonal antibodies) are available under EUA for early outpatient treatment.
See providers who offer this service »
See the parent category of this service »
You might also be interested in:
COVID-19 Immunization Home Visits (LT-3400.1530)
COVID-19 Immunization Clinics (LT-3400.1525)
Long Term COVID-19 Clinics (LT-1750.4460)
Diagnostic Blood Tests for Children's Inflammatory Illness (LF-4900.1710)
COVID-19 Test Results Hotlines (LF-4900.1568)
COVID-19 Test Home Collection Kits (LF-4900.1567)
COVID-19 Diagnostic Tests (LF-4900.1565)
COVID-19 Antibody Tests (LF-4900.1562)
Public Health Order Violations Reporting (JP-6650)
COVID-19 Control (JP-1500.1700-150)
COVID-19 Antibody Test Development (JP-1500.1520)
Fraudulent COVID-19 Test/Vaccine/Treatment Reporting (FN-1700.1470-215)
Contact Tracing Scam Reporting (FN-1700.1470-147)